Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16969290 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient
Condition: Kidney Transplant Immunosuppression
Interventions: Drug: adjustment of immunosuppressant dosages;   Drug: adjustment of the dosages of immunosuppressants

Indicates status has not been verified in more than two years